The latest announcement is out from California Nanotechnologies ( ($TSE:CNO) ). California Nanotechnologies has entered into a strategic agreement ...

Dozens of people asked the Seattle School Board’s newest members about the future of Seattle Public Schools during a Dec. 8 ...

California Nanotechnologies Corp. (TSXV: CNO) (OTCID: CANOF) ("Cal Nano" or the "Company") is pleased to announce it has ...

Investing.com -- Kyverna Therapeutics (NASDAQ:KYTX) stock surged 14% Monday after the company announced positive topline data from its registrational Phase 2 trial of mivocabtagene autoleucel (miv-cel ...

As organizations increasingly look to AI systems to transform the workspace, People and Talent professionals are being ...

Kyverna shares Phase 2 data showing single-dose CAR-T improved mobility and reduced disability in stiff person syndrome.

Bhubaneswar: Acting on a directive from the ministry of home affairs (MHA), Odisha police have instructed superintendents of police (SPs) to make exte.

Landmark results could pave the way for miv-cel to become the first FDA-approved CAR T-cell therapy for autoimmune disease; Company on track to ...

Kyverna Therapeutics looks all the more likely to win the first FDA approval for a CAR-T therapy in an autoimmune disease after a registrational trial showed “highly statistically significant” ...

Kyverna Therapeutics (NASDAQ:KYTX) shares climbed 14% on Monday after the company reported encouraging topline outcomes from ...

Bhubaneswar: In a stark illustration of the escalating unemployment crisis in Odisha, more than 8,000 candidates turned up on ...

Miv-cel was reported to be well tolerated in the KYSA-8 trial. No high-grade cases of cytokine release syndrome or immune ...